Related by context. All words. (Click for frequent words.) 69 warfarin dose 65 stratifying patients 64 electrophysiologic 64 warfarin dosing 64 pharmacodynamic parameters 63 postoperative complication 63 urine dipstick 63 conditional logistic regression 63 ARB telmisartan 63 genotypic resistance 63 warfarin anticoagulation 63 pretest probability 63 VKORC1 62 procalcitonin 62 differential gene expression 62 MDRD equation 62 hepatorenal syndrome 62 genes CYP#C# 62 leukocyte count 62 TPMT 62 abacavir Ziagen 62 antidiabetic medications 62 diagnostic modality 61 immunosuppressive regimen 61 multivariate logistic regression 61 poor metabolizers 61 multivariate regression analysis 61 epoetin alpha 61 warfarin therapy 61 oral anticoagulation 61 NIHSS score 61 ER CHOP 61 eNO 61 ACE Inhibitor 61 liver biopsies 61 antibiotic regimens 61 anagrelide 61 HAART regimen 61 antithrombotic therapy 61 somatostatin analogues 61 PROLARIS 61 pharmacogenetic testing 61 interferon ribavirin 60 logistic regression models 60 pretreatment serum 60 hemoglobin A1c levels 60 ORTHO EVRA R 60 aromatase inhibitor therapy 60 urine albumin 60 corticosteroid dose 60 coagulation parameters 60 mealtime insulin 60 antimicrobial prophylaxis 60 intima media thickness 60 International Normalized Ratio 60 radioiodine therapy 60 relapsed MM 60 myocardial viability 60 nutrient supplementation 60 glycosylated hemoglobin levels 60 pulmonary artery catheterization 60 d dimer 60 postoperative mortality 60 prognostic variables 60 anticoagulant medications 60 candidemia 60 antiplatelet therapies 60 atherosclerotic renal artery stenosis 60 glomerular filtration 60 prognostic indicators 60 NNT = 60 MTWA testing 60 chromosomal mutations 60 lipoprotein levels 60 albumin excretion 60 perinatal outcomes 60 multivariate Cox 60 mutated K ras 60 cardiac perfusion 60 immunosuppressive regimens 60 fibrate drugs 60 antiretroviral regimen 60 echocardiographic parameters 60 overt nephropathy 60 multivariable analysis 60 stepwise logistic regression 60 MS DRG 60 Cystatin C 60 resynchronization therapy 59 empiric therapy 59 eflornithine 59 glulisine 59 anti coagulant therapy 59 EuroSCORE 59 β blockers 59 pyridostigmine 59 HAART regimens 59 tracheal intubation 59 histopathologic diagnosis 59 Logistic regression 59 exhaled nitric oxide 59 multiple logistic regression 59 bolus dose 59 venous thromboembolism prophylaxis 59 CMV reactivation 59 anticoagulation therapy 59 Lantus insulin 59 anticoagulant medication 59 pre operatively 59 RAS mutations 59 glycated hemoglobin levels 59 antiplatelet medications 59 Fasting glucose 59 INVEGA ® 59 binary logistic regression 59 eTag assays 59 anticlotting drugs 59 Corus CAD 59 aspirin clopidogrel 59 hematologic parameters 59 salmeterol fluticasone 59 logistic regression analysis 59 pegylated IFN 59 serologic testing 59 nicardipine 59 tumor histology 59 steroid dexamethasone 59 Hydroxyurea 59 hematological parameters 59 corifollitropin alfa 59 PSADT 59 preoperative staging 59 cinacalcet 59 MDCT scans 59 glycosylated hemoglobin HbA1c 59 intra arterial chemotherapy 59 liver transplant recipients 59 Spartan RX CYP#C# 59 serum PTH 59 body habitus 59 aneuploidy screening 59 intravenous thrombolysis 59 therapeutic regimens 59 cytologic 59 ICD therapy 59 cardiopulmonary bypass surgery 59 hemodynamic parameters 59 IGRAs 59 timepoints 59 angiographic outcomes 59 ablative therapy 59 thrombus removal 59 AGHD 59 chest radiographs 59 antiarrhythmic drug 59 antithymocyte globulin 59 corticosteroid therapy 59 Poisson regression 59 transcranial Doppler 58 nonvertebral fracture 58 dose Iluvien 58 transvaginal sonography 58 fumagillin nanoparticles 58 BEXXAR Therapeutic Regimen 58 serum lipid levels 58 Renal Cell Carcinoma RCC 58 recursive partitioning 58 Pharmacokinetic parameters 58 perioperative morbidity 58 p# biomarker 58 tissue oxygenation 58 Insulin detemir 58 divalproex sodium 58 postoperative pulmonary 58 virological response 58 palivizumab 58 hemodynamic variables 58 platelet reactivity 58 postoperative AF 58 baseline LDH 58 coagulation abnormalities 58 #mg dose [002] 58 invasive aspergillosis 58 Starlix 58 bronchoalveolar lavage 58 VTE prophylaxis 58 metabolite concentrations 58 endometrial biopsy 58 Inhaled nitric oxide 58 OnDose TM 58 antiplatelet drugs 58 clevidipine 58 mixed hyperlipidemia 58 dorzolamide 58 RISPERDAL ® 58 hsCRP levels 58 microsatellite instability 58 von Willebrand 58 pulmonary artery banding 58 angiographically 58 Multivariate logistic regression 58 sputum specimens 58 multivariable Cox 58 intravesical therapy 58 bronchopulmonary dysplasia BPD 58 radiotherapy RT 58 DNA methylation markers 58 postoperative morbidity 58 antibody titer 58 lymphocyte count 58 sociodemographic factors 58 lipid lowering agents 58 Xelox 58 preoperative diagnosis 58 sonographic diagnosis 58 OnDose 58 Liver transplantation 58 eptifibatide 58 intravenous IV infusion 58 paracentesis 58 VerifyNow 58 NSTE ACS 58 antidiabetic medication 58 DXA scans 58 microdose 58 diagnosing ADHD 58 peripheral insulin sensitivity 58 beta interferons 58 troponins 58 prospective multicenter study 58 intermittent dosing 58 flecainide 58 myocardial infarct size 58 HER2 expression 58 Intravenous immunoglobulin 58 NRTI backbone 58 FDA defined valvulopathy 58 inflammatory biomarkers 58 EGFR mutation status 58 pharmacokinetic PK profile 58 aldosterone antagonist 58 NNRTI resistant virus 58 adverse cytogenetics 58 intraobserver 58 fluvastatin 58 ImmuKnow 58 debulking surgery 58 serum sodium levels 58 antibody titres 58 bronchoalveolar lavage BAL 58 thoracoscopic lobectomy 58 artery stenosis 58 obstructive CAD 58 CYP#D# genotype 58 coronary stenosis 58 Vidaza azacitidine 58 GAMMAGARD 58 Helicobacter pylori eradication 58 differentiate squamous 58 histological subtype 58 serum phosphorous 58 renal biopsy 58 miRview ™ squamous 58 perfusion CT 58 deCODE AF TM 58 thyroid stimulating hormone 58 transrectal ultrasound guided 58 standard chemotherapy regimens 58 serum phosphorus levels 58 hemoglobin A1c HbA1c 58 MMSE score 58 inhaled corticosteroid therapy 58 morphometric vertebral fractures 58 milliliters mL 58 posttransplant 58 oral anticoagulant therapy 58 TKI therapy 58 BENICAR HCT 58 patient subpopulations 58 zidovudine lamivudine 58 5-fluorouracil/leucovorin 57 dose titration 57 CHADS2 57 HSCT 57 antibiotic prophylaxis 57 allogeneic HSCT 57 tamoxifen Nolvadex ® 57 oral antidiabetic medication 57 multivariable regression 57 Phe restricted diet 57 diagnosing coronary artery 57 Cardiorespiratory fitness 57 Tumor Response 57 mealtime glucose 57 inotropic 57 OMS# 57 rt PA 57 PLAC test 57 labetalol 57 factorial design 57 MDCT angiography 57 multi analyte 57 hMG 57 prognostic biomarker 57 Acthar Gel 57 carotid revascularization 57 thromboprophylaxis 57 antihypertensive medications 57 fFN 57 ritonavir boosted protease inhibitor 57 preintervention 57 transient elastography 57 dosage regimens 57 Viral load 57 covariates 57 ritonavir boosted 57 HIV tropism 57 systemic hypotension 57 estimated GFR 57 cranial irradiation 57 chemoradiation therapy 57 systemic immunosuppressive drugs 57 QTcF 57 platelet inhibitor 57 Roche AmpliChip 57 diabetic kidney 57 biologic DMARDs 57 coronary CTA 57 postoperative infection 57 platelet inhibition 57 hormone receptor status 57 HbA 1c levels 57 symptomatic intracerebral hemorrhage 57 multivariate analyzes 57 APOE genotype 57 physiologic parameters 57 conventional angiography 57 Tasigna prolongs 57 maximal dose 57 induce remission 57 Levothyroxine 57 paricalcitol 57 leukotriene receptor antagonist 57 nitroprusside 57 microalbumin 57 IOP lowering 57 myocardial reperfusion 57 dopamine partial agonist 57 BYSTOLIC 57 aortic root replacement 57 leflunomide 57 neurodevelopmental outcome 57 IV bisphosphonates 57 haematologic 57 colorectal adenoma 57 reintubation 57 nonpharmacologic 57 intratympanic 57 TNF alpha inhibitor 57 cerebral angiography 57 plasma homocysteine 57 transcranial Doppler ultrasound 57 K ras mutations 57 nonsmall cell lung cancer 57 ImmuKnow R 57 thrombophilia 57 Pneumococcal vaccines 57 allergen avoidance 57 ICD shocks 57 induce ovulation 57 nomogram 57 Cardiotoxicity 57 prospective observational cohort 57 percutaneous vertebroplasty 57 genomewide 57 CPAP adherence 57 GeneSearch 57 calculated creatinine clearance 57 antihypertensive therapy 57 antithrombotic agent 57 CTAP# Capsules 57 serum lipid 57 MTHFD1L gene 57 Naive Patients 57 idiotype vaccine 57 empiric treatment 57 Cellcept 57 antiplatelet medication 57 pulmonary exacerbations 57 gonococcal infection 57 prasugrel Effient 57 serum aminotransferase levels 57 antiangiogenic agents 57 tardive dyskinesia TD 57 immunochemical fecal occult 57 anticoagulant warfarin 57 Dabigatran 57 moderate renal impairment 57 CAELYX 57 HepaMate 57 QTc prolongation 57 genomic biomarker 57 immunomodulatory therapy 57 cardioembolic stroke 57 COR Analyzer 57 TMP SMX 57 Thalomid ® 57 serum IgG 57 Oncotype 57 neurocognitive outcomes 57 Afib 57 percutaneous biopsy 57 antithrombotic therapies 57 antireflux surgery 57 PASI scores 57 nomograms 57 symptomatic VTE 57 APTIVUS 57 antiangiogenic drugs 57 intensive statin therapy 57 cerebral vasospasm 57 Framingham Risk Score 57 defibrillator implant 57 idraparinux 57 Antibiotic prophylaxis 57 homocysteine concentrations 57 angiographic restenosis 57 therapeutic radiopharmaceuticals 57 somatostatin analogs 57 mesalamine granules 57 D dimer 57 Surgical resection 57 logistic regression model 57 ribavirin RBV 57 thiazide diuretic 57 #.#mg dose 57 intravenous immunoglobulin IVIG 57 antiretroviral naïve 57 nucleotide analog 56 abacavir lamivudine 56 improves glycemic 56 severe renal impairment 56 leukotriene receptor antagonists 56 Coronary CTA 56 odds ratios ORs 56 Ivabradine 56 Tranexamic acid 56 griseofulvin 56 radiographic outcomes 56 Dacogen decitabine 56 Homocysteine levels 56 Procalcitonin 56 AGILECT R 56 Phenylketonuria PKU 56 hepatic liver 56 bolus dosing 56 ZOLINZA 56 hemoglobin hematocrit 56 TYGACIL 56 ABCB1 56 rFSH 56 Hb A1C 56 serum cortisol 56 systemic corticosteroids 56 rFVIIa 56 arteries dilate 56 pegylated alpha interferon 56 DVT prophylaxis 56 boosted protease inhibitor 56 neutrophil counts 56 colorectal cancer liver metastases 56 busulfan 56 induced sputum 56 pioglitazone HCl 56 serum potassium levels 56 oncologic outcomes 56 GnRH agonists 56 Estrogen Receptor 56 folinic acid 56 hematopoietic cancers 56 interobserver reliability 56 obstructive coronary artery 56 renoprotective 56 valvulopathy 56 abnormal cytology 56 noninvasive outpatient 56 adnexal mass 56 AST ALT 56 venous thromboembolic disease 56 transfusion syndrome 56 cardio metabolic 56 triglyceride concentrations 56 F FDG PET 56 antimicrobial susceptibility 56 bovine thrombin 56 ReoPro 56 vasogenic edema 56 basal bolus regimen 56 perfusion MRI 56 hyperbilirubinemia 56 thyroid hormone replacement 56 hip resurfacing arthroplasty 56 ALI ARDS 56 thyroid deficiency 56 asymptomatic hyperuricemia 56 NPM1 mutation 56 vascular insufficiency 56 Glomerular filtration rate 56 beta blocker atenolol 56 confounding variables 56 Postoperative complications 56 RE LY ® 56 dosing algorithm 56 enzyme immunoassay EIA 56 PRADAXA 56 Doppler echocardiography 56 hepatic tumors 56 Haptoglobin 56 metformin Glucophage 56 lyophilized formulation 56 hepatic insufficiency 56 tamponade 56 percutaneous drainage 56 capsular polysaccharide 56 logistic regression analyzes 56 PSA nadir 56 albumin excretion rate 56 PEGylated interferon 56 pegnivacogin 56 SPRIX ® 56 palliative radiotherapy 56 gliclazide 56 Multiple logistic regression 56 Heavy menstrual bleeding 56 colorectal liver metastases 56 hemodialysis patients 56 DSM IV diagnoses 56 inactivated influenza vaccines 56 nimodipine 56 thyroid hormone levels 56 concomitant medications 56 optimal dosing 56 chemotherapeutic regimen 56 pulmonary dysfunction 56 antitumor effect 56 renal artery stenting 56 metabolic parameters 56 serum creatinine levels 56 bacillus Calmette Guerin 56 hemostatic efficacy 56 patients undergoing CABG 56 parenteral antibiotics 56 Coronary Artery Bypass Graft 56 IV bolus 56 HALO# [002] 56 epoetin beta 56 gefitinib Iressa 56 hepatic function 56 Adjuvant chemotherapy 56 Dasatinib 56 levosimendan 56 pimecrolimus cream 56 tissue perfusion 56 diagnose Alzheimer disease 56 metformin sulphonylurea 56 randomized multicenter Phase III 56 EECP ® therapy 56 lung resection 56 INVEGA ™ 56 Hormonal therapy 56 Femara letrozole 56 FDG PET scans 56 immune globulins 56 multivariable logistic regression 56 MENOPUR 56 revascularization procedures 56 intrathecal chemotherapy 56 LPV r 56 pharmacodynamic properties 56 chorioamnionitis 56 parathyroidectomy 56 residual confounding 56 letrozole Femara 56 LPLD 56 Sustiva efavirenz 56 nadroparin 56 ventilatory 56 NATRECOR ® 56 acetabular fractures 56 SIMCOR 56 deep venous thromboses 56 tipranavir r 56 plasma triglycerides 56 metabolomic profiling 56 methylphenidate MPH 56 mild renal insufficiency 56 orofacial clefts 56 VerifyNow P#Y# 56 MULTAQ 56 BACcel 56 cerebral oximetry 56 rtPA 56 SUVmax 56 peg interferon 56 Vasotrac 56 anticoagulation clinics 56 QALY gained 56 Study GL# 56 Dosages 56 neurologic progression 56 FLECTOR R Patch 56 KRAS mutation 56 cerebral oxygen saturation 56 ACI TIPI 56 liposomal amphotericin B 56 Symptom severity 56 enoxaparin Lovenox 56 chemotherapeutic regimens 56 genotyping assay 56 mL/min/#.# m 2 56 dose dabigatran 56 methylation markers 56 thyroxine 56 serum LDL cholesterol 56 anticoagulation 56 AZT zidovudine Retrovir 56 Peg IFN 56 mammographic density 56 adenoma recurrence 56 lipid lowering therapy 56 anticoagulated 56 sulfonylurea metformin 56 guideline concordant 56 humoral responses 56 QT QTc interval 56 Twinrix 56 thrombotic complications 56 intravenous cyclophosphamide 56 Alteplase 56 pharmacologic treatments 56 TNF antagonist 56 femoral neck fracture 56 exemestane Aromasin 56 specific IgE 56 transabdominal 56 pamidronate 56 PITX2 56 Bacillus Calmette Guerin BCG 56 pharmacodynamic profile 56 Capsule endoscopy 56 pentoxifylline 56 HbA1C 56 postoperative infections 56 plasma pharmacokinetics 56 Hematocrit 56 physiologic responses 56 insulin glulisine 56 liposome formulation 56 intra abdominal abscess 56 metastatic neuroendocrine tumors 56 protease inhibitor PI 56 MDRD 56 nonfasting triglyceride levels 56 hepatectomy 56 CYP#D# gene 56 oral levofloxacin 56 HBsAg 55 co receptor tropism 55 colesevelam HCl 55 clinico pathological 55 HCV SPRINT 55 Animi 3 55 hypoxic ischemic encephalopathy HIE 55 serum bilirubin 55 Cardiopulmonary bypass 55 prospectively stratified 55 diagnostic prognostic 55 antiarrhythmic medications 55 CHAMPION PCI 55 autologous SCT 55 sensitivity specificity 55 antiepileptics 55 amoxicillin clavulanate 55 unicompartmental knee replacement 55 Lung transplantation 55 Resolute stent 55 plasma cortisol 55 Degarelix 55 multiple linear regression 55 transcatheter closure 55 parasitemia 55 fluticasone salmeterol 55 aCGH 55 diabetes mellitus DM 55 caspofungin 55 intact parathyroid hormone 55 virologic responses 55 sotalol 55 benazepril 55 maximally tolerated dose 55 lipid lowering therapies 55 risk stratification 55 biostatistical analysis 55 Pegylated Interferon 55 prehospital setting 55 Combination therapy 55 STELARA ™ 55 Lucrin 55 dopaminergic therapy 55 Reynolds Risk Score 55 biomarker assay 55 barium swallow 55 coronary revascularization 55 valganciclovir 55 adjunctive therapies 55 ribavirin USP 55 logistic regression 55 rHuEPO 55 corneal astigmatism 55 RX Acculink 55 CardioQ ODM 55 pegylated interferon alfa 55 sustained virologic response 55 surrogate markers 55 prostate cancer metastases 55 hemodynamically unstable 55 glycemia 55 quetiapine Seroquel 55 thromboembolic complications 55 multivariable analyzes 55 tumor subtype 55 platelet function 55 malabsorptive 55 neurodevelopmental impairment 55 REMINYL ® 55 elevated CRP 55 neurologic outcomes 55 atherogenic dyslipidemia 55 NIASPAN 55 bronchial hyperresponsiveness 55 receiving prophylactic anticoagulation 55 intracranial hemorrhage ICH 55 Liver biopsy 55 CMV infection 55 sitosterol 55 Teriparatide 55 analgesic medications 55 postoperative radiotherapy 55 Velcade bortezomib 55 Hemoglobin A1c 55 octreotide LAR 55 RhD 55 topical calcineurin inhibitors 55 cediranib 55 deCODE BreastCancer TM 55 INS# [002] 55 interferon alfa 55 intravenous diuretics 55 concurrent chemoradiation 55 Skin sterol 55 LV dysfunction 55 Intravitreal 55 miRview ™ mets 55 CINTREDEKIN BESUDOTOX 55 ratio ICER 55 HAQ DI 55 pancreatectomy 55 pharmacogenetic tests 55 mycophenolate mofetil MMF 55 Tumors shrank 55 preoperative chemotherapy 55 nuchal translucency 55 euglycemic clamp 55 plain radiographs 55 initiating antiretroviral therapy 55 Post operatively 55 containing abacavir 55 Creatinine 55 pretransplant 55 corticosteroid dexamethasone 55 Kaplan Meier curves 55 Calcium absorption 55 urothelial carcinoma 55 galiximab 55 dose regimens 55 coronary computed tomography 55 etanercept Enbrel 55 histologic subtype 55 pharmacological intervention 55 BLP# 55 daily subcutaneous injections 55 intraveneous 55 multivitamin supplementation 55 liver histology 55 statin monotherapy 55 NHAMCS 55 FOSRENOL ® 55 viral kinetics 55 G CSFs 55 fibrinolysis 55 oligohydramnios 55 HBV infections 55 fulvestrant 55 Allogeneic 55 STEP BD 55 Bonferroni correction 55 conjugate vaccines 55 CRT ICD 55 refractory angina 55 LDL HDL 55 tolevamer 55 inotropes 55 triacylglycerol concentrations 55 fentanyl citrate 55 IPAH 55 lipid lowering medication 55 aerosolized KL4 surfactant 55 opioid analgesia 55 adrenal function 55 teriflunomide 55 antifibrinolytic agents 55 ASCUS 55 histologically proven 55 meta regression 55 azacytidine 55 Islet transplantation 55 mycophenolate mofetil 55 Elitek 55 CORE OM 55 intravenous tPA 55 bronchoalveolar lavage fluid 55 virologically 55 Apatone 55 verteporfin 55 thalidomide Thalomid 55 reduce serum phosphate 55 inhibitor RG# 55 MYDICAR 55 Meta analyzes 55 MYCAMINE 55 FSH CTP 55 radioimmunoassay 55 Carotid artery stenting 55 trastuzumab Herceptin ® 55 indolent lymphomas 55 IgA deficiency 55 catheter angiography 55 HbA1C levels 55 antithrombotic agents 55 NN# [001] 55 diagnostic biomarker 55 Serum creatinine 55 Dose adjustments 55 ritonavir boosted lopinavir 55 ACTOplus met XR 55 atorvastatin #mg 55 tacrolimus ointment 55 inhaled nitric oxide 55 administered intramuscularly 55 GeneSightRx 55 transgenic rats 55 CYP#A# inhibitors 55 heFH 55 Coumadin warfarin 55 comorbid depression 55 edifoligide 55 ovarian hyperstimulation 55 chronic thromboembolic pulmonary 55 randomized controlled trials RCTs 55 nCPAP 55 intraoperative ultrasound 55 T1DM 55 FXIII 55 prostate cancer PCa 55 HBV vaccine 55 lowering systolic blood 55 beta adrenergic receptor 55 plasma creatinine 55 recurrent bladder 55 S. maltophilia 55 resectable pancreatic cancer 55 intradermal injections 55 dose atorvastatin 55 ejection fractions 55 pelvic lymphadenectomy 55 normothermia 55 clinically localized prostate 55 perioperative mortality 55 serum potassium 55 OncotypeDX 55 antifungal therapy 55 spirometric 55 A1PI 55 Adhibit 55 Diabetic Foot Ulcer 55 moderately emetogenic 55 NPH insulin 55 related bloodstream infections 55 Interferon beta 55 Monogram Trofile Assay 55 epidural steroid injection 55 lomitapide 55 LANTUS ® 55 intravenous tissue plasminogen 55 Danazol 55 transdermal estradiol 55 NSCLC tumors 55 Postoperatively 55 Index CDAI 55 VCUG 55 hyper IgE syndrome 55 urodynamic 55 sulphonylureas 55 Glomerular Filtration Rate 55 CIMZIA TM certolizumab pegol 55 anti angiogenic agents 55 multivariate regression 55 Kogenate ® FS 55 transarterial 55 bezafibrate 55 PD2i R 55 Evaluable 55 FDG-PET/CT 55 GnRH agonist 55 HOMA IR 55 DLQI 55 therapy Diamyd 55 K DOQI guidelines 55 Perforomist ™ Inhalation Solution 55 stratify patients 55 P. falciparum malaria 55 diagnose coronary artery 55 endocrinologic 55 operable breast cancer 55 creatinine levels 55 potential confounding variables 55 corrected QT interval 55 methotrexate monotherapy 55 severely immunocompromised patients 55 ATIR 55 antiandrogens 55 TURBT 55 Primary endpoints 55 Flow cytometry 55 alteplase 55 mg/# mL [002] 55 IL#B 55 FinESS Sinus Treatment 55 hypericin 55 risperidone Risperdal 55 ICD implantation 55 activated partial thromboplastin 55 zoledronate 55 serum TSH 55 NSABP B 55 postprandial glycemia 55 hepatic fibrosis 55 tissue plasminogen activator tPA 55 transthoracic 55 nonischemic 55 coronary arteriography 55 PD2i ® 55 BeneFIX 55 hemorrhagic complications 54 mycophenolic acid 54 antidiabetic drugs 54 Echocardiographic 54 ofpatients 54 trandolapril 54 chi squared 54 vidofludimus 54 inhospital mortality 54 Fetal Fibronectin Test 54 antiplatelet agents 54 bisoprolol 54 Alternans 54 oxygen saturations 54 dosing frequency 54 antiangiogenic therapy 54 NeuroSTAT ® 54 myocardial infarctions MIs 54 randomizing patients 54 pressure monitoring ABPM 54 neurocognitive impairment 54 euthyroid 54 PEG IFN 54 Azathioprine 54 pulmonary hypoplasia 54 Dural Sealant 54 RT PCR assay 54 vascular reactivity 54 percutaneous cryoablation 54 cTnI 54 monophasic 54 antiretroviral regimens 54 KRAS status 54 Ishak fibrosis score 54 LNG IUS 54 waist circumference WC